Antifungal-Associated Drug-Induced Cardiac Disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26567285.
- Also identified by DOI 10.1093/cid/civ739.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The etiology of cardiomyopathies are classified into 4 main groupings (dilated, hypertrophic, restrictive, and idiopathic) and can be mechanistically caused by myocarditis, conduction abnormalities, focal direct injury, or nutritional deficiency. Based on our review of this topic, evidence suggests that echinocandin-related cardiac dysfunction is a mitochondrial drug-induced disease caused by focal direct myocyte injury. With caspofungin or anidulafungin administration into the heart via central line, exposure is likely extreme enough to induce the acute toxicity. Chronic or low-dose exposure may lead to hypertrophic cardiomyopathy; however, only acute exposures have been explored to date.
Medical subject headings
- Antifungal Agents
- Cardiomyopathies
- Echinocandins
- Mitochondria, Heart